Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $70.0 to $150.0 for Novo Nordisk over the last 3 months.

After a boyfriend dumped me in my first year of high school, I developed an awful eating disorder and became insufferable to be around. I couldn’t eat without feeling the need to run afterwards. I ...

Last Patient / Last Visit Completed Topline Data Readout Expected Later This Quarter CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc.

A D.C. Superior Court Judge has awarded an historic Black church control over the Proud Boys trademark after the group ...

Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss KELOWNA, BC / ACCESS Newswire / February 5, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "L ...

Looking at options history for Novo Nordisk NVO we detected 8 trades. If we consider the specifics of each trade, it is ...

Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the ...

Global Partners LP (NYSE: GLP) released information regarding a cash distribution for its shareholders. The partnership declared a quarterly cash distribution of $0.7400 per unit ($2.96 per unit on an ...

(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...

UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment ...

“For more than five decades, Boston City Hall has served as a hub where residents come together to shape our city’s future, and has become a symbol of our city’s resilience, innovation, and commitment ...